Metirosine: Difference between revisions
m (Protected "Metirosine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 3: | Line 3: | ||
{{SI}} | {{SI}} | ||
==Mechanism of action== | ==Mechanism of action== | ||
'''Metirosine''' is an [[antihypertensive]] drug. It inhibits the enzyme [[tyrosine hydroxylase]] and, therefore, [[catecholamine]] synthesis. | '''Metirosine''' is an [[antihypertensive]] drug. It inhibits the enzyme [[tyrosine hydroxylase]] and, therefore, [[catecholamine]] synthesis. | ||
| Line 10: | Line 10: | ||
{{Antihypertensives and diuretics}} | {{Antihypertensives and diuretics}} | ||
[[Category:Antihypertensive agents]] | [[Category:Antihypertensive agents]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 17:24, 9 August 2012
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Pharmacokinetic data | |
| Elimination half-life | 3.4 - 3.7 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C10H13NO3 |
| Molar mass | 195.215 |
|
WikiDoc Resources for Metirosine |
|
Articles |
|---|
|
Most recent articles on Metirosine |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Metirosine at Clinical Trials.gov Clinical Trials on Metirosine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Metirosine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Metirosine Discussion groups on Metirosine Patient Handouts on Metirosine Directions to Hospitals Treating Metirosine Risk calculators and risk factors for Metirosine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Metirosine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Mechanism of action
Metirosine is an antihypertensive drug. It inhibits the enzyme tyrosine hydroxylase and, therefore, catecholamine synthesis.
Clinical Use
Metirosine is used in the treatment of phaeochromocytoma. It is contra-indicated for the treatment of essential hypertension.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antihypertensive agents